« Previous
Next »
Journal of Clinical Virology
Volume 29, Issue 3
, Pages 194-202
, March 2004
Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay
References
- . Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood. 1996;88:4063–4071
- . Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation. J. Med. Virol. 1997;52:200–205
- . Monitoring levels of human cytomegalovirus DNA in blood after liver transplantation. J. Clin. Microbiol. 1995;33:389–394
- . Virological diagnosis of cytomegalovirus in renal transplantation: comparison of three diagnostic methods: DNA in plasma by PCR, pp65 leukocytic antigenemia, and viremia. Transplant. Proc. 1996;28:2806–2807
- . Differences between the quantitative antigenemia assay and the cobas amplicor monitor quantitative PCR assay for detecting CMV viraemia in bone marrow and solid organ transplant patients. J. Med. Virol. 2001;64:275–282
- . Comparison of nested PCR for detection of DNA in plasma with pp65 leukocytic antigenemia procedure for diagnosis of human cytomegalovirus infection. J. Clin. Microbiol. 1994;32:1614–1618
- . Quantification of human cytomegalovirus DNA by real-time PCR. J. Clin. Microbiol. 2001;39:772–775
- . Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen. J. Clin. Microbiol. 1984;19:917–919
- . Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection. J. Clin. Microbiol. 2002;40:1767–1772
- . The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. J. Gen. Virol. 1992;73:2923–2932
- . Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR. J. Clin. Microbiol. 2001;39:4362–4369
- . Evaluation of CMV viral load using TaqMan CMV quantitative PCR and comparison with CMV antigenemia in heart and lung transplant recipients. Transplantation. 2001;71:1609–1615
- . Development and evaluation of a real-time quantitative PCR for the detection of human cytomegalovirus. J. Virol. Methods. 2001;95:121–131
- . TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency. Clin. Chem. 1999;45:982–986
-
.
Antigenemie leucocytaire cytomegalique quantitative. Interet clinique.
Presse. méd. 1995;24:534–536
- . Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation. J. Clin. Microbiol. 2000;38:2536–2542
- . Rapid detection of human cytomegalovirus viraemia from small volumes of heparinized whole blood. Res. Virol. 1993;144:169–171
-
Mengelle C et al. Quantitation of human cytomegalovirus in recipients solid organ transplants by real-time quantitative PCR and pp65 antigenemia. J Med Virol. In press.
- . Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxis. Bone Marrow Transplant. 1997;19:37–41
- . Different real-time PCR formats compared for the quantitative detection of human cytomegalovirus DNA. Clin. Chem. 1999;45:1932–1937
- . The polymerase chain reaction as a marker of cytomegalovirus infection in heart transplant recipients. Med. Clin. (Barc). 1999;112:121–124
- . Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems. J. Clin. Microbiol. 2001;39:4472–4476
- . Multiplex, quantitative real-time PCR assay for cytomegalovirus and human DNA. J. Clin. Microbiol. 2002;40:2381–2386
- . Qualitative plasma PCR assay (AMPLICOR CMV) test versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation. J. Clin. Microbiol. 2001;39:3938–3941
- . Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation. Transplantation. 1997;64:1721–1725
- . Quantitative analysis of cytomegalovirus load using a real-time PCR assay. J. Med. Virol. 2000;60:455–462
- . Prediction and diagnosis of cytomegalovirus disease in renal transplant recipients using qualitative and quantitative polymerase chain reaction. Transplantation. 2000;69:985–991
- . Cytomegalovirus (CMV) antigenemia: rapid diagnosis and relationship with CMV-associated clinical syndromes in renal allograft recipients. Transplant. Proc. 1989;21:2061–2064
- . Comparison of PCR, antigenemia assay, and rapid blood culture for detection and prevention of cytomegalovirus disease after lung transplantation. J. Clin. Microbiol. 2000;38(2):768–772
PII: S1386-6532(03)00124-0
doi: 10.1016/S1386-6532(03)00124-0
« Previous
Next »
Journal of Clinical Virology
Volume 29, Issue 3
, Pages 194-202
, March 2004
